These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3859212)
41. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group. Norrby SR; Finch RG; Glauser M J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130 [TBL] [Abstract][Full Text] [Related]
42. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside. Baruchel A; Hartmann O; Andremont A; Tancrède C J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190 [TBL] [Abstract][Full Text] [Related]
43. Imipenem/cilastatin vs. gentamicin/clindamycin for the treatment of moderate to severe infections in hospitalized patients. Guerra JG; Casalino E; Palomino JC; Barboza E; del Castillo M; Gonzalez del Riego M; Huapaya V; Antúnez de Mayolo E Rev Infect Dis; 1985; 7 Suppl 3():S463-70. PubMed ID: 3901209 [TBL] [Abstract][Full Text] [Related]
44. Imipenem/cilastatin therapy of bacteremia. Eron LJ Am J Med; 1985 Jun; 78(6A):95-9. PubMed ID: 3859221 [TBL] [Abstract][Full Text] [Related]
45. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin. Birnbaum J; Kahan FM; Kropp H; MacDonald JS Am J Med; 1985 Jun; 78(6A):3-21. PubMed ID: 3859213 [TBL] [Abstract][Full Text] [Related]
46. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections. Wang C; Pappas F; Cook T Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041 [TBL] [Abstract][Full Text] [Related]
47. Comparison of cefoperazone and mezlocillin with imipenem as empiric therapy in febrile neutropenic cancer patients. Mortimer J; Miller S; Black D; Kwok K; Kirby WM Am J Med; 1988 Jul; 85(1A):17-20. PubMed ID: 3400679 [TBL] [Abstract][Full Text] [Related]
48. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol]. Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723 [TBL] [Abstract][Full Text] [Related]
49. Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Wiseman LR; Wagstaff AJ; Brogden RN; Bryson HM Drugs; 1995 Jul; 50(1):73-101. PubMed ID: 7588092 [TBL] [Abstract][Full Text] [Related]
51. Imipenem/cilastatin as monotherapy in severe infections: comparison with cefotaxime in combination with metronidazole and cloxacillin. Report from a Norwegian Study Group. Scand J Infect Dis; 1987; 19(6):667-75. PubMed ID: 2894715 [TBL] [Abstract][Full Text] [Related]
52. Treatment of acute bacterial peritonitis: a trial of imipenem/cilastatin against ampicillin-metronidazole-gentamicin. Leaper DJ; Kennedy RH; Sutton A; Johnson E; Roberts N Scand J Infect Dis Suppl; 1987; 52():7-10. PubMed ID: 3331045 [TBL] [Abstract][Full Text] [Related]
53. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections. Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587 [TBL] [Abstract][Full Text] [Related]
55. [Efficacy and tolerance of imipenem/cilastatin in the treatment of surgical infections with and without bone involvement]. Voeckl J; Fischer M Infection; 1986; 14 Suppl 2():S154-9. PubMed ID: 3759250 [TBL] [Abstract][Full Text] [Related]
56. Imipenem-cilastatin in the treatment of respiratory infections in patients with chronic airways obstruction. Wathen CG; Carbarns NJ; Jones PA; Millar A; Croughan MJ; Calder MA; Douglas NJ J Antimicrob Chemother; 1988 Jan; 21(1):107-12. PubMed ID: 3356618 [TBL] [Abstract][Full Text] [Related]
57. Imipenem/cilastatin therapy of infections in cancer patients. Bodey GP; Elting L; Jones P; Alvarez ME; Rolston K; Fainstein V Cancer; 1987 Jul; 60(2):255-62. PubMed ID: 3297282 [TBL] [Abstract][Full Text] [Related]
58. [Clinical evaluation of imipenem/cilastatin sodium in the pediatric field]. Hirosawa H; Hoshina H; Morikawa Y; Ichihashi H Jpn J Antibiot; 1986 Jul; 39(7):1733-44. PubMed ID: 3464776 [TBL] [Abstract][Full Text] [Related]
59. Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program. Ong CT; Kuti JL; Nicolau DP; Surg Infect (Larchmt); 2005; 6(4):419-26. PubMed ID: 16433606 [TBL] [Abstract][Full Text] [Related]
60. [Fundamental and clinical studies on imipenem/cilastatin sodium in the pediatric field]. Toyonaga Y; Sugita M; Tsuda T; Takahashi T; Hori M Jpn J Antibiot; 1986 Jul; 39(7):1765-86. PubMed ID: 3464778 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]